Stay updated on Comparing TIP, TIS, and COLI in CF: Clinical Trial
Sign up to get notified when there's something new on the Comparing TIP, TIS, and COLI in CF: Clinical Trial page.

Latest updates to the Comparing TIP, TIS, and COLI in CF: Clinical Trial page
- Check5 days agoChange DetectedThe record displays details for a completed Phase IV cystic fibrosis study comparing tobramycin inhalation powder with nebulized tobramycin and colistimethate, including its design, eligibility criteria, outcomes, and study locations.SummaryDifference58%

- Check12 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check19 days agoChange DetectedA banner was added announcing changes to NIH websites and noting that some content may use “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check26 days agoChange DetectedThe ClinicalTrials.gov error page footer now shows revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check33 days agoChange DetectedThe ClinicalTrials.gov footer revision updated from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now displays a 403 Forbidden error and the study-specific content has been removed, leaving only the site header, navigation, and footer. The change affects access to the study record by removing the detailed content and replacing the page with a generic error view.SummaryDifference18%

Stay in the know with updates to Comparing TIP, TIS, and COLI in CF: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing TIP, TIS, and COLI in CF: Clinical Trial page.